Journal Articles
Most Viewed
Journal
Journal of Clinical Oncology
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
First Author: Charles L. Vogel
Publish Date: Mar 20, 2023
Journal
JCO Oncology Practice
Results From the ASCO 2019 Survey of Oncology Practice Operations
First Author: Brian Bourbeau
Publish Date: May 12, 2020
Journal
Journal of Clinical Oncology
Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot
First Author: Nicholas A. Ullman
Publish Date: Jul 1, 2022
Journal
Journal of Clinical Oncology
Assessing Clinical Trial–Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool
First Author: Marjorie J. Good
Publish Date: Mar 22, 2016
Recently Published
Journal
JCO Oncology Practice
Contextual Framework for Understanding Treatment De-Escalation in Patients With Breast Cancer
First Author: Atif J. Khan
Publish Date: Nov 22, 2024
Journal
JCO Precision Oncology
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types
First Author: Vijaykumar R. Holla
Publish Date: Nov 22, 2024
Journal
JCO Clinical Cancer Informatics
Using Machine Learning Models to Predict Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
First Author: Rayhan Erlangga Rahadian
Publish Date: Nov 22, 2024
Journal
JCO Precision Oncology
Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis
First Author: Jonathan N. Priantti
Publish Date: Nov 22, 2024
Journal
JCO Precision Oncology
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
First Author: Katherine E.R. Smith
Publish Date: Nov 22, 2024
Journal
JCO Precision Oncology
Lethal 5-Fluorouracil Toxicity in a Carrier of DPYD c.704G>A (p.R235Q)
First Author: Brianna M. Bembenek
Publish Date: Nov 22, 2024
Journal
JCO Precision Oncology
Sustained Response to Brigatinib in an Aggressive Relapsing Atypical Pituicytoma With ELM4-ALK Fusion
First Author: Pierre-Olivier Moser
Publish Date: Nov 22, 2024
Journal
Journal of Clinical Oncology
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial
First Author: Antonio Avallone
Publish Date: Nov 22, 2024